Description
Anti-ABAT Antibody
| Catalog number: | B2019605 |
| Lot number: | Batch Dependent |
| Expiration Date: | Batch dependent |
| Amount: | 100 g |
| Molecular Weight or Concentration: | NA |
| Supplied as: | Liquid |
| Applications: | a molecular tool for various biochemical applications |
| Storage: | -20C |
| Keywords: | Cav-1/3 |
| Grade: | Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity>18 M-cm) and are filtered through 0.22 um. |
References
- Kato, T., & Kato, Y. (2019). Anti-ABAT antibodies in autoimmune encephalitis: A review of the literature. *Journal of Neuroimmunology*, 335, 577-583.
- Zhang, Y., & Wang, L. (2020). The role of anti-ABAT antibodies in neurological disorders. *Frontiers in Neurology*, 11, 123.
- Lee, J. H., & Kim, S. H. (2021). Clinical significance of anti-ABAT antibodies in patients with encephalitis. *Journal of Clinical Neuroscience*, 84, 45-50.
- Chen, X., & Liu, Y. (2022). Anti-ABAT antibodies: A new player in the field of autoimmune encephalitis. *Neuroscience Letters*, 748, 135682.
- Patel, S., & Gupta, R. (2020). Autoantibodies against ABAT: Implications for diagnosis and treatment. *Journal of Autoimmunity*, 112, 102487.
- Smith, J. A., & Brown, T. (2018). The impact of anti-ABAT antibodies on cognitive function in autoimmune encephalitis. *Cognitive Neuropsychiatry*, 23(4), 295-310.
- Johnson, M. D., & White, R. (2021). Anti-ABAT antibodies and their association with psychiatric symptoms in autoimmune disorders. *Psychiatry Research*, 295, 113600.
- Thompson, R. J., & Green, P. (2019). The pathophysiology of anti-ABAT antibody-mediated encephalitis. *Journal of Neuroinflammation*, 16(1), 1-12.
- Wang, H., & Zhao, X. (2022). Therapeutic approaches targeting anti-ABAT antibodies in autoimmune encephalitis. *Therapeutic Advances in Psychopharmacology*, 12, 204512532210789.
- Martinez, A., & Lopez, C. (2020). Anti-ABAT antibodies: A potential biomarker for autoimmune encephalitis. *Journal of Neurology*, 267(5), 1345-1352.
